JDS Therapeutics, LLC Report issue

For profit

Organization Overview

First Clinical Trial
2020
NCT04544475
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

JDS Therapeutics, LLC

Active Ingredients

Drugs in Other Trials (1)

estradiol (progynon depot) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1